These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 7559504)
1. The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. Lomas DA; Stone SR; Llewellyn-Jones C; Keogan MT; Wang ZM; Rubin H; Carrell RW; Stockley RA J Biol Chem; 1995 Oct; 270(40):23437-43. PubMed ID: 7559504 [TBL] [Abstract][Full Text] [Related]
2. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620 [TBL] [Abstract][Full Text] [Related]
3. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. Chertov O; Ueda H; Xu LL; Tani K; Murphy WJ; Wang JM; Howard OM; Sayers TJ; Oppenheim JJ J Exp Med; 1997 Aug; 186(5):739-47. PubMed ID: 9271589 [TBL] [Abstract][Full Text] [Related]
4. Effect of alpha-1-proteinase inhibitor on neutrophil chemotaxis. Stockley RA; Shaw J; Afford SC; Morrison HM; Burnett D Am J Respir Cell Mol Biol; 1990 Feb; 2(2):163-70. PubMed ID: 2306372 [TBL] [Abstract][Full Text] [Related]
5. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis. Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of a selective inhibitor of elastase, cathepsin G and chymotrypsin on carrageenin-induced inflammation in rats. Nakagawa H; Kaneko M; Watanabe K; Sato K; Tsurufuji S J Pharmacobiodyn; 1986 Apr; 9(4):432-5. PubMed ID: 3637227 [TBL] [Abstract][Full Text] [Related]
7. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G. Bangalore N; Travis J Biol Chem Hoppe Seyler; 1994 Oct; 375(10):659-66. PubMed ID: 7888078 [TBL] [Abstract][Full Text] [Related]
8. Neutrophil-mediated proteolysis. Differential roles for cathepsin G and elastase. Kubes P; Smith R; Grisham MD; Granger DN Inflammation; 1993 Jun; 17(3):321-32. PubMed ID: 8330930 [TBL] [Abstract][Full Text] [Related]
9. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation. Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952 [TBL] [Abstract][Full Text] [Related]
10. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453 [TBL] [Abstract][Full Text] [Related]
11. Identification of factors from rat neutrophils responsible for cytotoxicity to isolated hepatocytes. Ho JS; Buchweitz JP; Roth RA; Ganey PE J Leukoc Biol; 1996 May; 59(5):716-24. PubMed ID: 8656057 [TBL] [Abstract][Full Text] [Related]
12. The inhibition of human neutrophil elastase and cathepsin G by peptidyl 1,2-dicarbonyl derivatives. Mehdi S; Angelastro MR; Burkhart JP; Koehl JR; Peet NP; Bey P Biochem Biophys Res Commun; 1990 Jan; 166(2):595-600. PubMed ID: 2302225 [TBL] [Abstract][Full Text] [Related]
13. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction. Liao CH; Cheng JT; Teng CM Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation. Renesto P; Chignard M Blood; 1993 Jul; 82(1):139-44. PubMed ID: 8324217 [TBL] [Abstract][Full Text] [Related]
15. Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors. Stefansson S; Yepes M; Gorlatova N; Day DE; Moore EG; Zabaleta A; McMahon GA; Lawrence DA J Biol Chem; 2004 Jul; 279(29):29981-7. PubMed ID: 15131125 [TBL] [Abstract][Full Text] [Related]
16. The chymotrypsin inhibitor carbobenzyloxy-leucine-tyrosine-chloromethylketone interferes with phospholipase D activation induced by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Kessels GC; Gervaix A; Lew PD; Verhoeven AJ J Biol Chem; 1991 Aug; 266(24):15870-5. PubMed ID: 1874738 [TBL] [Abstract][Full Text] [Related]
17. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Delclaux C; Delacourt C; D'Ortho MP; Boyer V; Lafuma C; Harf A Am J Respir Cell Mol Biol; 1996 Mar; 14(3):288-95. PubMed ID: 8845180 [TBL] [Abstract][Full Text] [Related]
18. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis. Kew RR; Grimaldi CM; Furie MB; Fleit HB J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin. Boudier C; Cadène M; Bieth JG Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091 [TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones. Harvath L; Yancey KB; Katz SI J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]